Ignite Creation Date:
2024-05-06 @ 2:52 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02145468
Status:
COMPLETED
Last Update Posted:
2017-06-02
First Post:
2014-05-15
Brief Title:
A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo LATITUDE-TIMI 60
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline